Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female.
Anti-Bacterial Agents
/ therapeutic use
Bronchiolitis
/ etiology
Bronchodilator Agents
/ therapeutic use
Ceftriaxone
/ therapeutic use
Coronavirus
Coronavirus Infections
/ complications
Female
Humans
Methylprednisolone
/ therapeutic use
Middle Aged
Obesity, Morbid
/ therapy
Oxygen
/ therapeutic use
Pericardial Effusion
/ etiology
Respiratory Insufficiency
/ etiology
Coronavirus
acute respiratory failure
bronchiolitis
virus infection
Journal
The Journal of asthma : official journal of the Association for the Care of Asthma
ISSN: 1532-4303
Titre abrégé: J Asthma
Pays: England
ID NLM: 8106454
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
pubmed:
28
4
2020
medline:
28
7
2021
entrez:
28
4
2020
Statut:
ppublish
Résumé
Seven species of coronavirus cause acute respiratory illness in humans. Coronavirus HKU 1 (CoV HKU 1) was first described in 2005 in an adult patient with pneumonia in Hong Kong. Although it is a well-known respiratory tract pathogen, there is not much information about its role in hospitalized adults, especially in southern Europe. Here, we describe a case of radiologically demonstrated CoV HKU 1-related bronchiolitis with acute respiratory failure in an adult female without significant comorbidities except obesity.
Identifiants
pubmed: 32336170
doi: 10.1080/02770903.2020.1761981
doi:
Substances chimiques
Anti-Bacterial Agents
0
Bronchodilator Agents
0
Ceftriaxone
75J73V1629
Oxygen
S88TT14065
Methylprednisolone
X4W7ZR7023
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM